Odimma Therapeutics
PrivateLast Round
Seed
May 2, 2023
Total Funding Raised
$4.41M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Odimma Therapeutics operates in Healthcare & Life Sciences and is based in Illkirch-Graffenstaden. Its latest recorded funding round was a Seed round in May 2023.
Odimma Therapeutics is a biotechnology company developing personalized cancer immunotherapy platforms powered by AI-driven neoantigen selection and synthetic DNA technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Odimma Therapeutics Comparables
Compare Odimma Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneos Therapeutics | 83% | |
| Boehringer Ingelheim | 76% | |
| EpiVax | 75% |
For institutional investors. Book with your work email.
Odimma Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 2, 2023 | ||||
| Seed | Dec 18, 2019 |
For institutional investors. Book with your work email.
Odimma Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MATWIN | Seed |
| Alsace Business Angels | Seed |
| Angels Santé | Seed |
| Capital Grand Est | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 181% MoM.
- Jun 1, 2025
Monthly visitors increased 799% MoM, reaching 620.
For institutional investors. Book with your work email.
Odimma Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Odimma Therapeutics's valuation, stock price, and market status.
Is Odimma Therapeutics a public or private company?
Odimma Therapeutics is a private company.
What is the current stock price of Odimma Therapeutics?
Odimma Therapeutics is a private company, so its shares have no public market price. Caplight tracks Odimma Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Odimma Therapeutics worth (valuation)?
Valuation information for Odimma Therapeutics is not publicly available.
Can I buy Odimma Therapeutics stock?
Odimma Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Odimma Therapeutics's last funding round?
Odimma Therapeutics's most recent funding round was Seed on May 2, 2023.
Who are the main investors in Odimma Therapeutics?
Key investors in Odimma Therapeutics include MATWIN, Alsace Business Angels, Angels Santé, Capital Grand Est, Bpifrance.
Will Odimma Therapeutics IPO soon?
No public IPO plans have been announced for Odimma Therapeutics.
How can I track Odimma Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Odimma Therapeutics's shares on secondary markets.